Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sucampo Pharma Inc (SCMP)

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 849,060
  • Shares Outstanding, K 47,170
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 60-Month Beta 1.38
  • Price/Sales 3.25
  • Price/Cash Flow N/A
  • Price/Book 21.18
Trade SCMP with:
  • Price/Earnings ttm 12.33
  • Earnings Per Share ttm 1.46
  • Most Recent Earnings 0.27 on 11/01/17
  • Next Earnings Date 03/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate 0.34
  • Number of Estimates 3
  • High Estimate 0.36
  • Low Estimate 0.32
  • Prior Year 0.68
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.85 +1.12%
on 01/24/18
18.30 -1.37%
on 01/17/18
unch (unch)
since 01/12/18
3-Month
10.10 +78.71%
on 11/16/17
18.75 -3.73%
on 01/08/18
+7.75 (+75.24%)
since 11/13/17
52-Week
9.30 +94.09%
on 04/18/17
18.75 -3.73%
on 01/08/18
+6.55 (+56.96%)
since 02/13/17

Most Recent Stories

More News
Worldwide Laxatives Industry to 2028 - Featuring Bayer, Purdue Pharma & Sucampo Pharmaceuticals Among Others

The "Laxatives Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2020 to 2028" report has been added to ResearchAndMarkets.com's...

SCMP : 18.05 (+0.28%)
Glaucoma Drugs Market Size | Global Industry Analysis and Opportunity Assessment 2021-2027

The latest research report on delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrate its growth trends and...

AERI : 18.39 (+16.32%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 72.62 (-2.68%)
NMUS : 0.6500 (-9.52%)
NVS : 85.91 (-0.92%)
OCAT : 8.47 (+0.12%)
OCUL : 18.34 (+1.27%)
OHRP : 5.39 (+30.19%)
PRGO : 40.36 (-1.03%)
PFE : 33.49 (-0.98%)
SNPHF : 13.6000 (-5.56%)
SCMP : 18.05 (+0.28%)
TEVA : 10.76 (-2.18%)
VRX.TO : 30.80 (-3.33%)
Irritable Bowel Syndrome Treatment Market Research during 2021-2027 Valeant Pharmaceuticals International, Sucampo Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals - The Courier

Rising prevalence of target disease, coupled with increasing uptake of drugs for the same, is driving the market. Furthermore, rising commercialization of existing products in different regions is expected...

ABT : 119.78 (-1.48%)
LXRX : 7.19 (-3.88%)
SCMP : 18.05 (+0.28%)
VRX.TO : 30.80 (-3.33%)
US Glaucoma Drugs Market Size 2021 By Trends Evaluation, Business Opportunities, Consumption, Growth Rate, Top Manufacturer, New Project Investment, Regional Analysis and Forecast to 2027

AI Market Report is working on a new report title Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027? Rise in prevalence of eye disorders such as Presbyopia, Macular Degeneration...

AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 72.62 (-2.68%)
NMUS : 0.6500 (-9.52%)
NVS : 85.91 (-0.92%)
OCAT : 8.47 (+0.12%)
OCUL : 18.34 (+1.27%)
OHRP : 5.39 (+30.19%)
PRGO : 40.36 (-1.03%)
PFE : 33.49 (-0.98%)
SNPHF : 13.6000 (-5.56%)
SCMP : 18.05 (+0.28%)
TEVA : 10.76 (-2.18%)
VRX.TO : 30.80 (-3.33%)
Constipation Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is estimated to value over USD 24.6 billion by 2027 end at a CAGR of over 6.9% during the forecast period 2020 to 2027.

ABT : 119.78 (-1.48%)
ALBO : 34.86 (-0.63%)
BAYRY : 15.2800 (-2.77%)
PBH : 41.71 (-0.14%)
SCMP : 18.05 (+0.28%)
SGYP : 0.03 (-52.00%)
VRX.TO : 30.80 (-3.33%)
Educative: Can Businesses recover from COVID-19 impact in Glaucoma Drugs Market

A recent report on provides a detailed analysis on the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles...

AERI : 18.39 (+16.32%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 72.62 (-2.68%)
NMUS : 0.6500 (-9.52%)
NVS : 85.91 (-0.92%)
OCAT : 8.47 (+0.12%)
OCUL : 18.34 (+1.27%)
OHRP : 5.39 (+30.19%)
PRGO : 40.36 (-1.03%)
PFE : 33.49 (-0.98%)
SNPHF : 13.6000 (-5.56%)
SCMP : 18.05 (+0.28%)
TEVA : 10.76 (-2.18%)
VRX.TO : 30.80 (-3.33%)
Frequency Therapeutics Appoints Peter Pfreundschuh as Chief Financial Officer

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases,...

IMMU : 87.86 (+0.05%)
SCMP : 18.05 (+0.28%)
URGN : 19.05 (-5.93%)
FREQ : 49.21 (-0.73%)
Irritable Bowel Syndrome Treatment Market Futuristic Comprehensive Insights with COVID-19 Impact Analysis | Abbott Laboratories, Synergy Pharmaceuticals Inc

A consciously conceived and designed business intelligence report titled Global  by Manufacturers, Type, and Application, Forecast to 2029 by discloses a succinct analysis of the regional spectrum,...

ABT : 119.78 (-1.48%)
ALPMF : 15.6600 (-3.57%)
GSK : 33.61 (-2.24%)
IRWD : 9.23 (+2.10%)
NVS : 85.91 (-0.92%)
SCMP : 18.05 (+0.28%)
SGYP : 0.03 (-52.00%)
VRX.TO : 30.80 (-3.33%)
Global Constipation Treatment Drug Market 2020 Key Drivers and Restraints, Regional Outlook, End-User Applicants by 2026

The recently distributed report entitled is well crafted using a combo of significant data related to the market. The report comprises a point by point knowledge about key aspects related to the global...

ABT : 119.78 (-1.48%)
ALBO : 34.86 (-0.63%)
BAYRY : 15.2800 (-2.77%)
IRWD : 9.23 (+2.10%)
PBH : 41.71 (-0.14%)
SCMP : 18.05 (+0.28%)
SGYP : 0.03 (-52.00%)
VRX.TO : 30.80 (-3.33%)
Constipation Treatment Drug Market Report 2026 Contains Review on Industry Size, Key Leading Companies and Opportunity by Geography

The "" 2020 report includes the market strategy, market orientation, expert opinion and knowledgeable information. The Constipation Treatment Drug Industry Report is an in-depth study analyzing the current...

ABT : 119.78 (-1.48%)
ALBO : 34.86 (-0.63%)
IRWD : 9.23 (+2.10%)
PBH : 41.71 (-0.14%)
SCMP : 18.05 (+0.28%)
SGYP : 0.03 (-52.00%)
VRX.TO : 30.80 (-3.33%)

Business Summary

Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of specialized medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products - AMITIZA, its lead product, and RESCULA - and a late-stage pipeline of product candidates in clinical...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 18.14
1st Resistance Point 18.07
Last Price 18.05
1st Support Level 17.94
2nd Support Level 17.88
3rd Support Level N/A

See More

52-Week High 18.75
Last Price 18.05
Fibonacci 61.8% 15.14
Fibonacci 50% 14.02
Fibonacci 38.2% 12.91
52-Week Low 9.30

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar